Acrivon AB vs Sinopia Biosciences
Acrivon AB vs Sinopia Biosciences, compared side by side on 17 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Acrivon AB is on 43/100 and Sinopia Biosciences on 54/100.
Where each one leads
Acrivon AB
- domain rating: 30/100 against 10/100
- funding raised: $10.0M against $2.2M
Sinopia Biosciences
- our overall score: 54/100 against 43/100
At a glance
| Measure | Acrivon AB | Sinopia Biosciences |
|---|---|---|
| What it is | Acrivon AB develops targeted therapies for cancer patients by matching drug mechanisms to the biologic drivers of cancer using their proprietary AP3 platform. | Biotechnology company advancing novel therapeutics using its proprietary LEADS drug discovery platform. |
| Category | AI Tools & Apps, AI Drug Discovery, Biotech, HealthTech | Biotechnology, Drug Discovery, Oncology, Biotech |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Platform |
| Founded | 2022 | 2017 |
| Headquarters | Uppsala, Sweden | San Diego, USA |
| Status | Active | Active |
Size, funding and growth
| Measure | Acrivon AB | Sinopia Biosciences |
|---|---|---|
| Total funding | $10.0M | $2.2M |
| Latest round | Seed | Grant |
| Valuation | Not published | $1.1B |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Acrivon AB | Sinopia Biosciences |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 43/100 | 54/100 |
| Traction | 35/100 | 32/100 |
| Team | 60/100 | 70/100 |
| Community | 15/100 | Not published |
| Search visibility | 5/100 | 15/100 |
| Quality | 50/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (40/100) | D (40/100) |
| Domain ratingLink authority, 0-100 | 30/100 | 10/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Acrivon AB | Sinopia Biosciences |
|---|---|---|
| CDN | Cloudflare | Not detected |
| CMS | WordPress | Squarespace |
| Frameworks | React | Not detected |
| Analytics | Google Analytics 4 | Not detected |
Acrivon AB vs Sinopia Biosciences: common questions
Which is better, Acrivon AB or Sinopia Biosciences?
On our 0-100 score Sinopia Biosciences rates higher (54/100 against 43/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 17 data points above: read the rows that match what you are buying for.
How do Acrivon AB and Sinopia Biosciences compare on the numbers?
Acrivon AB leads on domain rating (30/100 against 10/100), funding raised ($10.0M against $2.2M). Sinopia Biosciences leads on our overall score (54/100 against 43/100).
Read the full Acrivon AB review and pricing or the Sinopia Biosciences review and pricing. You can also browse other Acrivon AB alternatives we track.